PADIS

Pubblicazioni Aperte DIgitali Sapienza > MEDICINA SPERIMENTALE > FISIOPATOLOGIA E CLINICA DELL'APPARATO SCHELETRICO >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10805/1152

Title: BONE MINERAL METABOLISM IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 (VON RECKLINGAUSEN DISEASE)"
Authors: PETRAMALA, LUIGI
Tutor: LETIZIA, CLAUDIO
Keywords: neurofibromatosis type 1
osteoporosis
vitamin D
bone mineral alterations
Issue Date: Oct-2011
Abstract: The neurofibromatosis type 1 is characterized by specific cutaneous features (neurofibromas, “café-au-lait” spots of the skin) and alterations of several tissue (nervous, vascular) and bone deformities, such as scoliosis, congenital pseudoarthrosis of the tibia and dysplasia. Moreover, several studies have shown systemic involvement of bone tissue in NF1 patients, leading to reduced bone mass. Aim of our study was to evaluate some bone mineral metabolism parameters before and after calcium and vitamin D supplementation in NF1 patients. We evaluated in 70 NF1 consecutive patients the mineral metabolism and bone mineral density compared to 40 normal subjects (NS). We showed bone alterations in 35% of patients and the increase of bone formation markers, such as bone isoenzyme of alkaline phosphatase (41.2±15.5 UI vs. 25.6±8.7UI, p<0.05) and osteocalcin (18.1±5.6 ng/ml vs 7.6±1.9 ng/ml; p<0.05), reduction of circulating levels of (25OH)-vitamin D (21.8±12.3 ng/ml) with an high percentage of hypovitaminosys D (>60%). Moreover, we revealed a significant reduction of bone mass density at spine (L1-L4) (0.935±0.13 gr/cm2 vs 1.110±0.17 gr/cm2; p <0.001) and femoral neck side (FN) (0.765±0.09 gr/cm2 vs 0.839±0.12 gr/cm2; p<0.02), with high prevalence of osteoporosis (18%) and osteopenia (44%). After 12-months of calcium (1200mg/die) and cholecalciferol supplementation (800UI/die) we found a significant increase of (25)OH-vitamin D level (21.8±12.3 ng/mL vs 35±13 ng/mL; p <0.01) without changes in bone mass density. In conclusion, NF1 patients may present mineral bone involvement, with vitamin D deficiency; Calcium and vitamin D supplementation is necessary to restore these bone mineral metabolic alterations.
URI: http://hdl.handle.net/10805/1152
Research interests: internal medicine; endocrine diseases; arterial hypertension; bone diseases; obesity
Skills short description: internal medicine; endocrine diseases; arterial hypertension; bone diseases; obesity
Personal skills keywords: endocrine diseases
internal medicine
arterial hypertension
bone diseases
obesity
Appears in PhD:FISIOPATOLOGIA E CLINICA DELL'APPARATO SCHELETRICO

Files in This Item:

File Description SizeFormat
paper.docArticolo principale completo369.5 kBMicrosoft Word

File del Curriculum Vitae:

CurriculumVitae. Petramala dottorato.doc 71 kBMicrosoft Word


This item is protected by original copyright

Recommend this item

Items in PADIS are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback Sviluppo e manutenzione a cura del CINECA